卡地纳健康

US · CAH #429 按市值排名上市于 1970

254.06 +0.35 +0.14%

实时 - 追踪5344个代码 - 心跳于14秒前 · 2026-10-16 20:02

✦ 量化股权信号计算方式说明

增持

最近一期（2026/Q3）披露持股的机构数量减少了6家。
机构持股总比例上升了0.4个百分点。

机构持股

机构持股比例: 90.80% +0.42pp
机构数量: 1,739 -6
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund74.83%

Public Company4.74%

Hedge Fund3.31%

Private Company3.07%

Government Pension Fund2.22%

Sovereign Wealth Fund1.68%

Family Office/Trust0.31%

Insurance Company0.30%

Corporate Pension Plan0.14%

Other9.40%

主要股东截至 2026-06-30

BlackRock 11.44% · 26.49M 股

Vanguard Capital Management, LLC 7.18% · 16.62M 股

Wellington Management Group 6.42% · 14.86M 股

Vanguard Portfolio Management, LLC 5.92% · 13.72M 股

State Street Global Advisors 5.17% · 11.97M 股

Geode Capital Management, LLC 2.80% · 6.47M 股

WCM Investment Management 1.78% · 4.11M 股

Norges Bank Investment Management 1.61% · 3.73M 股

UBS Asset Management 1.36% · 3.15M 股

Morgan Stanley 1.24% · 2.87M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 26次买入 · 24次卖出

姓名	职务	持股比例
Jason Hollar	Chief Executive Officer	0.05%
Deborah Weitzman	Chief Executive Officer of Pharmaceutical Segment	0.03%
Stephen Mason	Chief Executive Officer of Medical segment	0.01%
Jessica Mayer	Chief Legal & Compliance Officer	0.01%
Ola Snow	Chief Human Resources Officer	0.01%
Patricia Hemingway Hall	Independent Director	0.00%
Michelle Greene	Executive VP, Chief Information Officer & Customer Support Services	0.00%
Michelle Brennan	Independent Director	0.00%
Valerie Pitteroff	Chief Human Resources Officer	0.00%
Sheri Edison	Independent Director	0.00%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-08-18	Jason Hollar	Chief Executive Officer	Open Market Disposition	-124,529	$233.22–237.88
2026-08-18	Mary Scherer	Chief Accounting Officer	Open Market Disposition	-2,302	$237.39–237.40
2026-08-17	Aaron Alt	Chief Financial Officer	Open Market Disposition	-42,000	$234.55–237.26
2026-08-17	Deborah Weitzman	Chief Executive Officer of Pharmaceutical Segment	Open Market Disposition	-7,354	$235.30–237.44
2026-08-17	Jessica Mayer	Chief Legal & Compliance Officer	Open Market Disposition	-29,436	$234.64–237.31
2026-08-17	Stephen Mason	Chief Executive Officer of Medical segment	Open Market Disposition	-35,000	$234.59–237.26
2026-08-17	Michelle Greene	Executive VP, Chief Information Officer & Customer Support Services	Open Market Disposition	-11,650	$234.57–237.25
2026-08-14	Jason Hollar	Chief Executive Officer	Sale to Issuer	-103,449	$235.17
2026-08-14	Jason Hollar	Chief Executive Officer	Other Acquisition	+30,616	--
2026-08-14	Aaron Alt	Chief Financial Officer	Sale to Issuer	-30,730	$235.17
2026-08-14	Aaron Alt	Chief Financial Officer	Other Acquisition	+8,079	--
2026-08-14	Deborah Weitzman	Chief Executive Officer of Pharmaceutical Segment	Sale to Issuer	-29,759	$235.17
2026-08-14	Deborah Weitzman	Chief Executive Officer of Pharmaceutical Segment	Other Acquisition	+7,314	--
2026-08-14	Jessica Mayer	Chief Legal & Compliance Officer	Sale to Issuer	-25,285	$235.17
2026-08-14	Jessica Mayer	Chief Legal & Compliance Officer	Other Acquisition	+6,378	--
2026-08-14	Stephen Mason	Chief Executive Officer of Medical segment	Sale to Issuer	-25,289	$235.17
2026-08-14	Stephen Mason	Chief Executive Officer of Medical segment	Other Acquisition	+5,868	--
2026-08-14	Michelle Greene	Executive VP, Chief Information Officer & Customer Support Services	Sale to Issuer	-10,031	$235.17
2026-08-14	Michelle Greene	Executive VP, Chief Information Officer & Customer Support Services	Other Acquisition	+2,551	--
2026-08-14	Mary Scherer	Chief Accounting Officer	Sale to Issuer	-1,757	$235.17

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:18 · 仅供参考，不构成投资建议，也未考虑您的具体情况。